[1]. Galanie S., Thodey K., Trenchard I.J., Filsinger Interrante M., Smolke C.D., Complete biosynthesis of opioids in yeast, Science, 2015, 349:1095 [Crossref], [Google Scholar], [Publisher] [2]. Presley C.C., Lindsley C.W., DARK classics in chemical neuroscience: opium, a historical perspective, ACS Chemical Neuroscience, 2018, 9:2503 [Crossref], [Google Scholar], [Publisher] [5]. Terry J.G., Braumoeller F.L., Nalline: An aid in detecting narcotic users, California Medicine, 1956, 85:299 [Crossref], [Google Scholar], [Publisher] [6]. Gruba S.M., Francis D.H., Meyer A.F., Spanolios E., He J., Meyer B.M., Kim D., Xiong-Hang K., Haynes C.L., Characterization of the presence and function of platelet opioid receptors, ACS Measurement Science Au, 2021, 2:4 [Crossref], [Google Scholar], [Publisher] [7]. Obeng S., Hiranita T., León F., McMahon L.R., McCurdy C.R., Novel approaches, drug candidates, and targets in pain drug discovery, Journal of medicinal chemistry, 2021, 64:6523 [Crossref], [Google Scholar], [Publisher] [8]. Kaboudin B., Sohrabi M., Chemistry and synthesis of major opium alkaloids: a comprehensive review, Journal of the Iranian Chemical Society, 2021, 18:3177 [Crossref], [Google Scholar], [Publisher] [11]. Lochner J., Structural Biochemistry and the Opioid Crisis: Using the Primary Literature to Teach Core Concepts and Underscore the Societal Relevance of Biochemical Research, The FASEB Journal, 2019, 33:617 [Crossref], [Google Scholar], [Publisher] [12]. a) Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology, 11th Edition: McGraw-Hill Education, 2009 [Crossref], [Google Scholar], [Publisher], b) McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods: Elsevier, 2017 [Crossref], [Google Scholar], [Publisher] [15]. Devulder J., Bohyn P., Castille F., De Laat M., Rolly G., A case of uncommon withdrawal symptoms after a short period of spinal morphine administration, Pain, 1996, 64:589 [Crossref], [Google Scholar], [Publisher] [18]. Cruz S.L., Granados-Soto V., Opioids and opiates: pharmacology, abuse, and addiction, Neurosci 21st century. New York: Springer, 2016, 3625 [Crossref], [Google Scholar], [Publisher] [19]. Aronson JK. Meyler's Side Effects of Drugs 15E: The International Encyclopedia of Adverse Drug Reactions and Interactions: Newnes, 2014 [Crossref], [Google Scholar], [Publisher] [20]. Kanamori T., Okada Y., Segawa H., Yamamuro T., Kuwayama K., Tsujikawa K., Iwata Y.T., Agonistic activity of fentanyl analogs and their metabolites on opioid receptors, Forensic Toxicology, 2022, 40:156 [Crossref], [Google Scholar], [Publisher] [21]. Rodrigues S., Shin D., Conway M., Stefanie S., Emily T., Harsha S., Thuva V., Lehana T., James P., Hydromorphone versus morphine: A historical cohort study to evaluate the quality of postoperative analgesia, Canadian Journal of Anesthesia, 2021, 68:226 [Crossref], [Google Scholar], [Publisher] [22]. Aronson J.K., Lennard M.S., Ritter J.M., Baber N.S., Begg E.J., Lewis L.D., Today's science, tomorrow's medicines. British Journal of Clinical Pharmacology, 2006, 61:1 [Crossref], [Google Scholar], [Publisher] [23]. Melzack R., Wall P.D., Pain Mechanisms: A New Theory: A gate control system modulates sensory input from the skin before it evokes pain perception and response, Science, 1965, 150:971 [Crossref], [Google Scholar], [Publisher] [24]. Osterweis M., Kleinman A., Mechanic D., Pain and disability: Clinical, behavioral, and public policy perspectives, 1987 [Crossref], [Google Scholar], [Publisher] [25]. Hosseinzadeh A., Kamrava S.K. Joghataei M.T., Darabi R., Shakeri‐Zadeh A., Shahriari M., Reiter R.J., Ghaznavi H., Mehrzadi S., Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin, Journal of Pineal Research, 2016, 61:411 [Crossref], [Google Scholar], [Publisher] [26]. Osterweis M., Kleinman A., Mechanic D., Pain and disability: Clinical, behavioral, and public policy perspectives, 1987 [Crossref], [Google Scholar], [Publisher] [27]. Yam M.F., Loh Y.C., Tan C.S., Khadijah Adam S., Abdul Manan N., Basir R., General pathways of pain sensation and the major neurotransmitters involved in pain regulation, International Journal of Molecular Sciences, 2018, 19:2164 [Crossref], [Google Scholar], [Publisher] [28]. Froehlich J.C., Opioid peptides, Alcohol Health and Research World, 1997, 21:132 [Google Scholar], [Publisher] [29]. Dafny N., Pain Modulation and Mechanisms (Section 2, Chapter 8) Neuroscience Online: An Electronic Textbook for the Neurosciences: Department of Neurobiology and Anatomy - The University of Texas Medical School at Houston [Crossref], [Google Scholar], [Publisher] [30]. Mosberg H.I., Yeomans L., Anand J.P., Porter V., Sobczyk-Kojiro K., Traynor J.R., Jutkiewicz E.M., Development of a bioavailable μ opioid receptor (MOPr) agonist, δ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance, Journal of Medicinal Chemistry, 2014, 57:3148 [Crossref], [Google Scholar], [Publisher] [31]. Yamamoto T., Nair P., Jacobsen N.E., Davis P., Ma S.w., Navratilova E., Moye S., Lai J., Yamamura H.I., Vanderah T.W., The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for δ/μ opioid receptor agonists and neurokinin 1 receptor antagonists, Journal of Medicinal Chemistry, 2008, 51:6334 [Crossref], [Google Scholar], [Publisher] [32]. Yeagle P., Membrane Receptors, The Membranes of Cells, 3rd ed.; Academic Press: Boston, MA, USA, 2016, 401 [Google Scholar], [Publisher] [33]. Panyam J., Labhasetwar V., Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles, Molecular pharmaceutics, 2004, 1:77 [Crossref], [Google Scholar], [Publisher] [34]. Wärnmark A., Treuter E., Wright A.P., Gustafsson J.A., Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation, Molecular endocrinology, 2003, 17:1901 [Crossref], [Google Scholar], [Publisher] [35]. Spetea M., Schmidhammer H., Recent chemical and pharmacological developments on 14-oxygenated-N-methylmorphinan-6-ones, Molecules, 2021, 26:5677 [Crossref], [Google Scholar], [Publisher] [36]. Kareem Z.Y., McLaughlin P.J., Kumari R., Opioid growth factor receptor: Anatomical distribution and receptor colocalization in neurons of the adult mouse brain, Neuropeptides, 2023, 99:102325 [Crossref], [Google Scholar], [Publisher] [37]. Edinoff A.N., Martinez Garza D., Vining S.P., Vasterling M.E., Jackson E.D., Murnane K.S., Kaye A.M., Fair R.N., Torres Y.J.L., Badr A.E., New Synthetic Opioids: Clinical Considerations and Dangers, Pain and Therapy, 2023, 12:399 [Crossref], [Google Scholar], [Publisher] [38]. Li Y., Lefever M.R., Muthu D., Bidlack J.M., Bilsky E.J., Polt R., Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins, Future Medicinal Chemistry, 2012, 4:205 [Crossref], [Google Scholar], [Publisher] [39]. Toubia T., Khalife T., The endogenous opioid system: role and dysfunction caused by opioid therapy, Clinical Obstetrics and Gynecology, 2019, 62:3 [Crossref], [Google Scholar], [Publisher] [41]. Machelska H., Celik M.Ö., Advances in achieving opioid analgesia without side effects, Frontiers in Pharmacology, 2018, 9:1388 [Crossref], [Google Scholar], [Publisher] [42]. Faouzi A., Zaidi S., Che T., Kormos C., Zhang T., Madasu M., Eans S., Simons C., Pan Y.X., McLaughlin J., Design of first in class bitopic ligands targeting the sodium binding pocket in opioid receptors, The FASEB Journal, 2020, 34:1 [Crossref], [Google Scholar], [Publisher] [43]. Faouzi A., Uprety R., Gomes I., Massaly N., Keresztes A.I., Le Rouzic V., Gupta A., Zhang T., Yoon H.J., Ansonoff M., Synthesis and pharmacology of a novel μ–δ opioid receptor heteromer-selective agonist based on the carfentanyl template, Journal of medicinal chemistry, 2020, 63:13618 [Crossref], [Google Scholar], [Publisher] [44]. Lee Y.S., Nyberg J., Moye S., Agnes R.S., Davis P., Ma S.w., Lai J., Porreca F., Vardanyan R., Hruby V.J., Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at μ and δ opioid receptors, Bioorganic & Medicinal Chemistry Letters, 2007, 17:2161 [Crossref], [Google Scholar], [Publisher] [45]. Endoma M.A., Butora G., Claeboe C.D., Hudlicky T., Abboud K.A., Chemoenzymatic and electrochemical oxidations in the synthesis of octahydroisoquinolines for conversion to morphine. Relative merits of radical vs. acid-catalyzed cyclizations, Tetrahedron Letters, 1997, 38:8833 [Crossref], [Google Scholar], [Publisher] [46]. Guerrero M., Urbano M., Kim E.K., Gamo A.M., Riley S., Abgaryan L., Leaf N., Van Orden L.J., Brown S.J., Xie J.Y.,  Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist,  Journal of Medicinal Chemistry, 2019, 62:1761 [Crossref], [Google Scholar], [Publisher] [47]. Mohamud A.O., Zeghal M., Patel S., Laroche G.v., Blgacim N., Giguère P.M., Functional Characterization of Sodium Channel Inhibitors at the Delta-Opioid Receptor, ACS Omega, 2022, 7:16939 [Crossref], [Google Scholar], [Publisher] [49]. Herbert M., Holzer P., Warum versagen substanz P (NK1)-rezeptorantagonisten in der schmerztherapie?, Der Anaesthesist, 2002, 51:308 [Crossref], [Google Scholar], [Publisher] [50]. Latorraca N.R., Venkatakrishnan A., Dror R.O., GPCR dynamics: structures in motion, Chemical reviews, 2017, 117:139 [Crossref], [Google Scholar], [Publisher] [51]. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr F.J., Civelli O., Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor, Science, 1995, 270:792 [Crossref], [Google Scholar], [Publisher] [52]. Malafoglia V., Ilari S., Vitiello L., Tenti M., Balzani E., Muscoli C., Raffaeli W., Bonci A., The interplay between chronic pain, opioids, and the immune system, The Neuroscientist, 2022, 28:613 [Crossref], [Google Scholar], [Publisher] [53]. Bluth M.H., Pincus M.R., Narcotic analgesics and common drugs of abuse: Clinical correlations and laboratory assessment, Clinics in Laboratory Medicine, 2016, 36:603 [Crossref], [Google Scholar], [Publisher] [54]. Stewart A., Fisher R.A., Introduction: G protein-coupled receptors and RGS proteins, Progress in Molecular Biology and Translational science, 2015, 133:1 [Crossref], [Google Scholar], [Publisher] [55]. Holtman Jr J.R. in Anesthesiology In-Training Exam Review: Regional Anesthesia and Chronic Pain     191 (Springer, 2022). [Crossref], [Google Scholar], [Publisher] [56]. Hansen K., Wollmuth L., Traynelis S., 6.2 Structure-Function Correlates of Glutamate-Gated Ion Channels, in Comprehensive Biophysics     4 (Elsevier BV, 2012). [Crossref], [Google Scholar], [Publisher] [57]. a) Wang X., Zhang Y., Peng Y., Hutchinson M., Rice K., Yin H., Watkins L., Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4, British journal of pharmacology, 2016, 173:856 [Crossref], [Google Scholar], [Publisher]. b) Wenthur C.J., Lindsley C.W., Classics in chemical neuroscience: clozapine, ACS Chemical Neuroscience, 2013, 4:1018 [Crossref], [Google Scholar], [Publisher] [58]. a) Modarresi-Alam A.R., Khamooshi F., Nasrollahzadeh M., Amirazizi H.A., Silica supported perchloric acid (HClO4–SiO2): an efficient reagent for the preparation of primary carbamates under solvent-free conditions, Tetrahedron, 2007, 63:8723 [Crossref], [Google Scholar], [Publisher] b) Modarresi-Alam A.R., Nasrollahzadeh M., Khamooshi F., Solvent-free preparation of primary carbamates using silica sulfuric acid as an efficient reagent, Arkivoc, 2007, 16:238 [Crossref], [Google Scholar], [Publisher] c) Modarresi-Alam A.R., Khamooshi F., Rostamizadeh M., Keykha H., Nasrollahzadeh M., Bijanzadeh H.R., Kleinpeter E., Dynamic 1H NMR spectroscopic study of the restricted SN rotation in aryl-N-(arylsulfonyl)-N-(triphenylphosphoranylidene) imidocarbamates, Journal of Molecular Structure, 2007, 841:61 [Crossref], [Google Scholar], [Publisher] d) Modarresi‐Alam A.R., Khamooshi F., A One‐Pot Synthesis of Aryl‐N‐[(4‐methylphenylsulfonyl)]‐N‐(triphenylphosphoranylidene) imidocarbamates from 5‐Aryloxytetrazoles, Synthetic Communications, 2004, 34:129 [Crossref], [Google Scholar], [Publisher] e) Khamooshi F., Modarresi-Alam A.R., Solvent-free preparation of arylaminotetrazole derivatives using aluminum (III) hydrogensulfate as an effective catalyst, Chinese Chemical Letters, 2010, 21:892 [Google Scholar], [Publisher] f) Khamooshi F., Mousavi S., Bonjar S., Zolfigol M., Anti-HIV drugs study: Study of NNRTIs function and overview synthesis of specific and rare aryloxy tetrazoles derivatives as NNRTIs and anti-HIV drug, Medicon Pharmaceutical Sciences, 2022, 2:04 [Google Scholar], [Publisher] g) Sultana S., Sonia Z.A., Mahmud M., Mottakin M., Haider J.B., Ahmed S., Hossen M.M., An Investigation of Cellulose, Hemicellulose and Lignin Co-Extraction from Water Hyacinth, Advanced Journal of Chemistry Section A, 2024, 7:75 [Crossref], [Google Scholar], [Publisher] h) Soltani Z, Hoseinzadeh M, Saboor FH. Biomass Gasification Process Enhancing using Metal-Organic Frameworks. Advanced Journal of Chemistry, Section A. 2024, 7:89 [Crossref], [Google Scholar], [Publisher]. i) Orouji A., Ghasemi F., Hormozi-Nezhad M.R., Machine Learning-Assisted Colorimetric Assay Based on Au@Ag Nanorods for Chromium Speciation. Analytical Chemistry, 2023, 95:10110 [Crossref], [Google Scholar], [Publisher] j) Zamani Esfahlani M, Irajian M. The Relationship between Osteomyelitis of Long Bones and Mortality in Patients Admitted to the Intensive Care Unit. Eurasian Journal of Science and Technology, 2023:1 [Crossref], [Google Scholar], [Publisher]. k) Thakur BN, Satpathy I, Patnaik BCM, Kumar A. Artificial intelligence (AI): cancer treatment revolution in India. Journal of Medicinal and Pharmaceutical Chemistry Research, 2023, 5:1089 [Crossref], [Google Scholar], [Publisher] [59]. a)Khamooshi F., Haghighi B., Jhaleh K., Aryan R., Alam A.M., Rezvani A., Mirzaei A., Maghsoodlou M., Solvent-free preparation of 5-aryloxytetrazoles via [2+3] cycloaddition of cyanates and sodium azide using silica supported sulfuric acid as an effective heterogeneous catalyst, Chemistry of Heterocyclic Compounds, 2014, 49:1464 [Crossref], [Google Scholar], [Publisher] b) Khamooshi F., KekhaiyeJhaleh B., ZnCL2/ALCL3/silica (ZAS) as an effective heterogeneous catalyst for the synthesis of 5-aryloxy tetrazoles, Chemistry Journal of Moldova, 2012, 7:130 [Crossref], [Google Scholar], [Publisher] c) Khamooshi F., Kekhaiye Jhaleh B.H., New synthetic methods for the preparation of 5-aryloxytetrazoles with using Mg(HSO4)2 and AL2O3-SO3H as efficient and green heterogeneous catalysts under solvent-free conditions, Journal of the Chilean Chemical Society, 2013, 58:1691 [Crossref], [Google Scholar], [Publisher] d) Modarresi-Alam A.R., Pakseresht M., Khamooshi F., Identification of solvent and perchlorate anion-dependent polaron mutations during the new polymerization of new aniline composites and nanocomposites. Polymer Bulletin. 2023 [In press] e) Khamooshi F., Akinnawo A.S., Doraji-Bonjar S., Modarresi-Alam A.R., Mitragynine Chemistry; Extraction, Synthesis and Clinical Effects. Chemistry Africa. 2023, [In press] f) Kohanfekr T., Hakimi M., Hassani H., Ali Hosseini H., Synthesis, Characterization, and Antimicrobial Studies on a New Schiff Base Complex of Vanadium (V). Chemical Methodologies, 2023, 7:748 [Crossref], [Google Scholar], [Publisher] g) Kumari P., Sengar M.S., Sengar N., A Mini Review on Lactic Acidosis Effect, Cause, Symptoms, Complications, Metabolism, and Pathodology with Its Diagnosis, Treatment, and Preventions. Journal of Chemical Reviews. 2023, 27 [Crossref], [Google Scholar], [Publisher] h) Ghalandarzehi Y., Kord-Tamandani H., Experimental and Theoretical Study on the Mechanism and Kinetics of the Reaction between Hexamethyl Phosphorous Triamide and Dialkyl Acetylenedicarboxylates in the Presence of Benzimidazole. Chemical Methodologies, 2023, 7:776 [Crossref], [Google Scholar], [Publisher]i) Darroudi M., Nazari S.E., Karimzadeh M., Asgharzadeh F., Asghari S.Z., Khalili-Tanha N., Rezayi M., Khazaei M., Fabrication of magnetic nanocomposite as responsive drug delivery vehicle for cervical cancer therapy. Applied Organometallic Chemistry, 2023, 37:e7068 [Crossref], [Google Scholar], [Publisher] j) Abdulrahman Hamad O., Kareem R.O., Khdir Omer P., Recent Developments in Synthesize, Properties, Characterization, and Application of Phthalocyanine and Metal Phthalocyanine. Journal of Chemical Reviews, 2023, 39 [Crossref], [Google Scholar], [Publisher] [60]. Yin H., Gerlach L.O., Miller M.W., Moore D.T., Liu D., Vilaire G., Bennett J.S. and DeGrado W.F., Arylamide derivatives as allosteric inhibitors of the integrin α2β1/type I collagen interaction. Bioorganic & Medicinal Chemistry Letters, 2006, 16:3380 [Crossref], [Google Scholar], [Publisher] [61]. Zhang J., Yang F., Qiao Z., Zhu M., Zhou H., Chalcone–benzoxaborole hybrids as novel anticancer agents. Bioorganic & Medicinal Chemistry Letters, 2016, 26:5797 [Crossref], [Google Scholar], [Publisher] [62]. Bhutani P., Joshi G., Raja N., Bachhav N., Rajanna P.K., Bhutani H., H., Paul, A.T., Kumar R., U.S. FDA Approved Drugs from 2015–June 2020: A Perspective. Journal of Medicinal Chemistry, 2021, 64:2339 [Crossref], [Google Scholar], [Publisher]. [63]. Paweł K., Magdalena L., Structural Analogy —Direct Similarity versus Topographical Complementarity. 2015. In: Drug Discovery and Development [Internet]. Rijeka: IntechOpen; [Ch. 11] [Crossref], [Google Scholar], [Publisher] [64]. a) Sacerdote P., Levrini L., Peripheral Mechanisms of Dental Pain: The Role of Substance P. Mediators of Inflammation. 2012, 2012:951920 [Crossref], [Google Scholar], [Publisher] b) Chang C-T., Jiang B-Y., Chen C-C., Ion Channels Involved in Substance P-Mediated Nociception and Antinociception. International Journal of Molecular Sciences, 2019, 20 [Crossref], [Google Scholar], [Publisher] [65]. a) A